Dupont Capital Management Corp Ani Pharmaceuticals Inc Transaction History

Dupont Capital Management Corp

  • $1.18 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

May 02, 2018
SELL
$56.98 - $72.41 $1.04 Million - $1.32 Million
-18,251 Closed
0 $0
Q4 2017

Jan 31, 2018
BUY
$53.3 - $74.56 $516,157 - $722,039
9,684 Added 113.04%
18,251 $1.18 Million
Q3 2017

Oct 31, 2017
BUY
$43.46 - $52.49 $372,321 - $449,681
8,567
8,567 $450,000

Others Institutions Holding ANIP

# of Institutions
211
Shares Held
18.7M
Call Options Held
11.7K
Put Options Held
10.5K
View Full List

About ANI PHARMACEUTICALS INC

ANIP Quotes by TradingView
  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $944M
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Dupont Capital Management Corp Portfolio

Follow Dupont Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Dupont Capital Management Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email